IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sofinnova Management VIII, L.L.C.

Q4 2017 Holdings

Filed 2018-02-14 | 8 holdings | $38.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics, Inc.(ACRS)Common Stock00461U105$38.0M1,539,48099.6%
NuCana plcAmerican Depositary Shares67022C106$47.2K4,666,6660.1%
ObsEva SACommon StockH5861P103$46.4K4,749,6230.1%
Spark Therapeutics, Inc.Common Stock84652J103$24.7K481,2700.1%
Natera, Inc.(NTRA)Common Stock632307104$13.9K1,550,2800.0%
Auris Medical Holding AGCommon SharesH03579101$4.6K7,818,1750.0%
Histogenics CorporationCommon Stock43358V109$4.3K2,077,0400.0%
Synlogic, Inc.Common Stock87166L100$4.1K424,9720.0%